The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications

Abstract

Polymeric biomaterials have found widespread applications in nanomedicine, and poly(lactide-co-glycolide), (PLGA) in particular has been successfully implemented in numerous drug delivery formulations due to its synthetic malleability and biocompatibility. However, the need for preconception in these formulations is increasing, and this can be achieved by selection and elimination of design variables in order for these systems to be tailored for their specific applications. The starting materials and preparation methods have been shown to influence various parameters of PLGA-based nanocarriers and their implementation in drug delivery systems, while the implementation of computational simulations as a component of formulation studies can provide valuable information on their characteristics. This review provides a critical summary of the synthesis and applications of PLGA-based systems in bio-medicine and outlines experimental and computational design considerations of these systems.

Systemically-delivered biodegradable PLGA alters gut microbiota and induces transcriptomic reprogramming in the liver in an obesity mouse model

“…Poly (lactic- co -glycolic acid) (PLGA) is one of the most common biodegradable, FDA-approved polymers used in modern medicine and has enjoyed a long history of use as a scaffold/carrier for injectable drugs, vaccines and implantable devices 1 . In the exponentially developing field of drug delivery, nanoparticles (NPs) made of PLGA are a delivery vehicle of first choice, owing to their good biocompatibility, stability, increased safety and modifiable biodegradation rates, thus reducing dosage and potential drug toxicity.…”

Curcumin Formulations and Trials: What’s New in Neurological Diseases

“…Curcumin acts on Aβ levels, deposits, and aggregation in a multitude of ways. In vitro studies demonstrated that compounds derived from curcumin protect PC12 cells against Aβ (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35) and Aβ(1-42) insult [49]. When used as a pretreatment, curcumin prevents Aβ-induced toxicity in the human SH-SY5Y neuroblastoma cell line by increasing mRNA and protein levels of mitochondrial genes, such as nuclear respiratory factor 1 (Nrf1) and mitochondrial transcription factor A (TFAM) [50].…”

Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects

“…According to the previously described characteristics of a nanoparticulate delivery structure, investigations about the use of different materials as nanocarrier precursors are an essential requirement for the improvement of the applicability and results achieved by these systems. These precursors should meet some requisites such as biocompatibility, biodegradability and non-immunogenicity [ 6 ]. Polymers are macromolecules formed by the covalent union of one or different sort of units, named monomers, to constitute a linear or branched chain.…”